Form 8k- After the offering .. COH and possible uses.
The burn rate until news gave Insmed aprx 45-50 Million going into 2014 and filing mid year with a 2015 hopeful Launch in Europe.With $67.0 million, you may want to ask why the company raised the cash now?.
as a funny sideshow to any that might think this is not really all contrived for the gullible, please note who made millions pushing this offering.
"Leerink Swann LLC acted as sole book-running manager for the offering. Lazard Capital Markets LLC and Canaccord Genuity acted as co-managers of the offering. "
A week before he offering PR.
Canaccord reiterates its Buy rating - $18
Leerink reiterates its Buy rating - $22
Lazard reiterates its Buy rating - $24
"6 million for the world market" , but is the US CF market spoken for?...Lewis stated they are taking the data to Europe. The possibly using the money for another indication,(beside CF and NTM) then its game on.otherwise I strongly suspect the selling we are seeing will continue. Good Luck